Expansion based on codesystem Vaccine Administered Code Set (CVX) version20231214
| Code | System | Display | Synonym | English (English, en) |
| 01 |
http://hl7.org/fhir/sid/cvx |
DTP |
diphtheria, tetanus toxoids and pertussis vaccine |
diphtheria, tetanus toxoids and pertussis vaccine |
| 02 |
http://hl7.org/fhir/sid/cvx |
OPV |
trivalent poliovirus vaccine, live, oral |
trivalent poliovirus vaccine, live, oral |
| 03 |
http://hl7.org/fhir/sid/cvx |
MMR |
measles, mumps and rubella virus vaccine |
measles, mumps and rubella virus vaccine |
| 04 |
http://hl7.org/fhir/sid/cvx |
M/R |
measles and rubella virus vaccine |
measles and rubella virus vaccine |
| 05 |
http://hl7.org/fhir/sid/cvx |
measles |
measles virus vaccine |
measles virus vaccine |
| 06 |
http://hl7.org/fhir/sid/cvx |
rubella |
rubella virus vaccine |
rubella virus vaccine |
| 07 |
http://hl7.org/fhir/sid/cvx |
mumps |
mumps virus vaccine |
mumps virus vaccine |
| 08 |
http://hl7.org/fhir/sid/cvx |
Hep B, adolescent or pediatric |
hepatitis B vaccine, pediatric or pediatric/adolescent dosage |
hepatitis B vaccine, pediatric or pediatric/adolescent dosage |
| 09 |
http://hl7.org/fhir/sid/cvx |
Td (adult), 2 Lf tetanus toxoid, preservative free, adsorbed |
tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (2 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid) |
tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (2 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid) |
| 10 |
http://hl7.org/fhir/sid/cvx |
IPV |
poliovirus vaccine, inactivated |
poliovirus vaccine, inactivated |
| 11 |
http://hl7.org/fhir/sid/cvx |
pertussis |
pertussis vaccine |
pertussis vaccine |
| 12 |
http://hl7.org/fhir/sid/cvx |
diphtheria antitoxin |
diphtheria antitoxin |
diphtheria antitoxin |
| 13 |
http://hl7.org/fhir/sid/cvx |
TIG |
tetanus immune globulin |
tetanus immune globulin |
| 14 |
http://hl7.org/fhir/sid/cvx |
IG, unspecified formulation |
immune globulin, unspecified formulation |
immune globulin, unspecified formulation |
| 15 |
http://hl7.org/fhir/sid/cvx |
influenza, split (incl. purified surface antigen) |
influenza virus vaccine, split virus (incl. purified surface antigen)-retired CODE |
influenza virus vaccine, split virus (incl. purified surface antigen)-retired CODE |
| 16 |
http://hl7.org/fhir/sid/cvx |
influenza, whole |
influenza virus vaccine, whole virus |
influenza virus vaccine, whole virus |
| 17 |
http://hl7.org/fhir/sid/cvx |
Hib, unspecified formulation |
Haemophilus influenzae type b vaccine, conjugate unspecified formulation |
Haemophilus influenzae type b vaccine, conjugate unspecified formulation |
| 18 |
http://hl7.org/fhir/sid/cvx |
rabies, intramuscular injection |
rabies vaccine, for intramuscular injection RETIRED CODE |
rabies vaccine, for intramuscular injection RETIRED CODE |
| 19 |
http://hl7.org/fhir/sid/cvx |
BCG |
Bacillus Calmette-Guerin vaccine |
Bacillus Calmette-Guerin vaccine |
| 20 |
http://hl7.org/fhir/sid/cvx |
DTaP |
diphtheria, tetanus toxoids and acellular pertussis vaccine |
diphtheria, tetanus toxoids and acellular pertussis vaccine |
| 21 |
http://hl7.org/fhir/sid/cvx |
varicella |
varicella virus vaccine |
varicella virus vaccine |
| 22 |
http://hl7.org/fhir/sid/cvx |
DTP-Hib |
DTP-Haemophilus influenzae type b conjugate vaccine |
DTP-Haemophilus influenzae type b conjugate vaccine |
| 23 |
http://hl7.org/fhir/sid/cvx |
plague |
plague vaccine |
plague vaccine |
| 24 |
http://hl7.org/fhir/sid/cvx |
anthrax |
anthrax vaccine |
anthrax vaccine |
| 25 |
http://hl7.org/fhir/sid/cvx |
typhoid, oral |
typhoid vaccine, live, oral |
typhoid vaccine, live, oral |
| 26 |
http://hl7.org/fhir/sid/cvx |
cholera, unspecified formulation |
cholera vaccine, unspecified formulation |
cholera vaccine, unspecified formulation |
| 27 |
http://hl7.org/fhir/sid/cvx |
botulinum antitoxin |
botulinum antitoxin |
botulinum antitoxin |
| 28 |
http://hl7.org/fhir/sid/cvx |
DT (pediatric) |
diphtheria and tetanus toxoids, adsorbed for pediatric use |
diphtheria and tetanus toxoids, adsorbed for pediatric use |
| 29 |
http://hl7.org/fhir/sid/cvx |
CMVIG |
cytomegalovirus immune globulin, intravenous |
cytomegalovirus immune globulin, intravenous |
| 30 |
http://hl7.org/fhir/sid/cvx |
HBIG |
hepatitis B immune globulin |
hepatitis B immune globulin |
| 31 |
http://hl7.org/fhir/sid/cvx |
Hep A, pediatric, unspecified formulation |
hepatitis A vaccine, pediatric dosage, unspecified formulation |
hepatitis A vaccine, pediatric dosage, unspecified formulation |
| 32 |
http://hl7.org/fhir/sid/cvx |
meningococcal MPSV4 |
meningococcal polysaccharide vaccine (MPSV4) |
meningococcal polysaccharide vaccine (MPSV4) |
| 33 |
http://hl7.org/fhir/sid/cvx |
pneumococcal polysaccharide PPV23 |
pneumococcal polysaccharide vaccine, 23 valent |
pneumococcal polysaccharide vaccine, 23 valent |
| 34 |
http://hl7.org/fhir/sid/cvx |
RIG |
rabies immune globulin |
rabies immune globulin |
| 35 |
http://hl7.org/fhir/sid/cvx |
tetanus toxoid, adsorbed |
tetanus toxoid, adsorbed |
tetanus toxoid, adsorbed |
| 36 |
http://hl7.org/fhir/sid/cvx |
VZIG |
varicella zoster immune globulin |
varicella zoster immune globulin |
| 37 |
http://hl7.org/fhir/sid/cvx |
yellow fever |
yellow fever vaccine |
yellow fever vaccine |
| 38 |
http://hl7.org/fhir/sid/cvx |
rubella/mumps |
rubella and mumps virus vaccine |
rubella and mumps virus vaccine |
| 39 |
http://hl7.org/fhir/sid/cvx |
Japanese encephalitis SC |
Japanese Encephalitis Vaccine SC |
Japanese Encephalitis Vaccine SC |
| 40 |
http://hl7.org/fhir/sid/cvx |
rabies, intradermal injection |
rabies vaccine, for intradermal injection |
rabies vaccine, for intradermal injection |
| 41 |
http://hl7.org/fhir/sid/cvx |
typhoid, parenteral |
typhoid vaccine, parenteral, other than acetone-killed, dried |
typhoid vaccine, parenteral, other than acetone-killed, dried |
| 42 |
http://hl7.org/fhir/sid/cvx |
Hep B, adolescent/high risk infant |
hepatitis B vaccine, adolescent/high risk infant dosage |
hepatitis B vaccine, adolescent/high risk infant dosage |
| 43 |
http://hl7.org/fhir/sid/cvx |
Hep B, adult |
hepatitis B vaccine, adult dosage |
hepatitis B vaccine, adult dosage |
| 44 |
http://hl7.org/fhir/sid/cvx |
Hep B, dialysis |
hepatitis B vaccine, dialysis patient dosage |
hepatitis B vaccine, dialysis patient dosage |
| 45 |
http://hl7.org/fhir/sid/cvx |
Hep B, unspecified formulation |
hepatitis B vaccine, unspecified formulation |
hepatitis B vaccine, unspecified formulation |
| 46 |
http://hl7.org/fhir/sid/cvx |
Hib (PRP-D) |
Haemophilus influenzae type b vaccine, PRP-D conjugate |
Haemophilus influenzae type b vaccine, PRP-D conjugate |
| 47 |
http://hl7.org/fhir/sid/cvx |
Hib (HbOC) |
Haemophilus influenzae type b vaccine, HbOC conjugate |
Haemophilus influenzae type b vaccine, HbOC conjugate |
| 48 |
http://hl7.org/fhir/sid/cvx |
Hib (PRP-T) |
Haemophilus influenzae type b vaccine, PRP-T conjugate |
Haemophilus influenzae type b vaccine, PRP-T conjugate |
| 49 |
http://hl7.org/fhir/sid/cvx |
Hib (PRP-OMP) |
Haemophilus influenzae type b vaccine, PRP-OMP conjugate |
Haemophilus influenzae type b vaccine, PRP-OMP conjugate |
| 50 |
http://hl7.org/fhir/sid/cvx |
DTaP-Hib |
DTaP-Haemophilus influenzae type b conjugate vaccine |
DTaP-Haemophilus influenzae type b conjugate vaccine |
| 51 |
http://hl7.org/fhir/sid/cvx |
Hib-Hep B |
Haemophilus influenzae type b conjugate and Hepatitis B vaccine |
Haemophilus influenzae type b conjugate and Hepatitis B vaccine |
| 52 |
http://hl7.org/fhir/sid/cvx |
Hep A, adult |
hepatitis A vaccine, adult dosage |
hepatitis A vaccine, adult dosage |
| 53 |
http://hl7.org/fhir/sid/cvx |
typhoid, parenteral, AKD (U.S. military) |
typhoid vaccine, parenteral, acetone-killed, dried (U.S. military) |
typhoid vaccine, parenteral, acetone-killed, dried (U.S. military) |
| 54 |
http://hl7.org/fhir/sid/cvx |
adenovirus, type 4 |
adenovirus vaccine, type 4, live, oral |
adenovirus vaccine, type 4, live, oral |
| 55 |
http://hl7.org/fhir/sid/cvx |
adenovirus, type 7 |
adenovirus vaccine, type 7, live, oral |
adenovirus vaccine, type 7, live, oral |
| 56 |
http://hl7.org/fhir/sid/cvx |
dengue fever tetravalent |
dengue fever vaccine, tetravalent |
dengue fever vaccine, tetravalent |
| 57 |
http://hl7.org/fhir/sid/cvx |
hantavirus |
hantavirus vaccine |
hantavirus vaccine |
| 58 |
http://hl7.org/fhir/sid/cvx |
Hep C |
hepatitis C vaccine |
hepatitis C vaccine |
| 59 |
http://hl7.org/fhir/sid/cvx |
Hep E |
hepatitis E vaccine |
hepatitis E vaccine |
| 60 |
http://hl7.org/fhir/sid/cvx |
herpes simplex 2 |
herpes simplex virus, type 2 vaccine |
herpes simplex virus, type 2 vaccine |
| 61 |
http://hl7.org/fhir/sid/cvx |
HIV |
human immunodeficiency virus vaccine |
human immunodeficiency virus vaccine |
| 62 |
http://hl7.org/fhir/sid/cvx |
HPV, quadrivalent |
human papilloma virus vaccine, quadrivalent |
human papilloma virus vaccine, quadrivalent |
| 63 |
http://hl7.org/fhir/sid/cvx |
Junin virus |
Junin virus vaccine |
Junin virus vaccine |
| 64 |
http://hl7.org/fhir/sid/cvx |
leishmaniasis |
leishmaniasis vaccine |
leishmaniasis vaccine |
| 65 |
http://hl7.org/fhir/sid/cvx |
leprosy |
leprosy vaccine |
leprosy vaccine |
| 66 |
http://hl7.org/fhir/sid/cvx |
Lyme disease |
Lyme disease vaccine |
Lyme disease vaccine |
| 67 |
http://hl7.org/fhir/sid/cvx |
malaria |
malaria vaccine |
malaria vaccine |
| 68 |
http://hl7.org/fhir/sid/cvx |
melanoma |
melanoma vaccine |
melanoma vaccine |
| 69 |
http://hl7.org/fhir/sid/cvx |
parainfluenza-3 |
parainfluenza-3 virus vaccine |
parainfluenza-3 virus vaccine |
| 70 |
http://hl7.org/fhir/sid/cvx |
Q fever |
Q fever vaccine |
Q fever vaccine |
| 71 |
http://hl7.org/fhir/sid/cvx |
RSV-IGIV |
respiratory syncytial virus immune globulin, intravenous |
respiratory syncytial virus immune globulin, intravenous |
| 72 |
http://hl7.org/fhir/sid/cvx |
rheumatic fever |
rheumatic fever vaccine |
rheumatic fever vaccine |
| 73 |
http://hl7.org/fhir/sid/cvx |
Rift Valley fever |
Rift Valley fever vaccine |
Rift Valley fever vaccine |
| 74 |
http://hl7.org/fhir/sid/cvx |
rotavirus, tetravalent |
rotavirus, live, tetravalent vaccine |
rotavirus, live, tetravalent vaccine |
| 75 |
http://hl7.org/fhir/sid/cvx |
vaccinia (smallpox) |
vaccinia (smallpox) vaccine |
vaccinia (smallpox) vaccine |
| 76 |
http://hl7.org/fhir/sid/cvx |
Staphylococcus bacterio lysate |
Staphylococcus bacteriophage lysate |
Staphylococcus bacteriophage lysate |
| 77 |
http://hl7.org/fhir/sid/cvx |
Tick-borne encephalitis vaccine (non-US) |
Tick-borne encephalitis vaccine (non-US) |
Tick-borne encephalitis vaccine (non-US) |
| 78 |
http://hl7.org/fhir/sid/cvx |
tularemia vaccine |
tularemia vaccine |
tularemia vaccine |
| 79 |
http://hl7.org/fhir/sid/cvx |
vaccinia immune globulin |
vaccinia immune globulin |
vaccinia immune globulin |
| 80 |
http://hl7.org/fhir/sid/cvx |
VEE, live |
Venezuelan equine encephalitis, live, attenuated |
Venezuelan equine encephalitis, live, attenuated |
| 81 |
http://hl7.org/fhir/sid/cvx |
VEE, inactivated |
Venezuelan equine encephalitis, inactivated |
Venezuelan equine encephalitis, inactivated |
| 82 |
http://hl7.org/fhir/sid/cvx |
adenovirus, unspecified formulation |
adenovirus vaccine, unspecified formulation |
adenovirus vaccine, unspecified formulation |
| 83 |
http://hl7.org/fhir/sid/cvx |
Hep A, ped/adol, 2 dose |
hepatitis A vaccine, pediatric/adolescent dosage, 2 dose schedule |
hepatitis A vaccine, pediatric/adolescent dosage, 2 dose schedule |
| 84 |
http://hl7.org/fhir/sid/cvx |
Hep A, ped/adol, 3 dose |
hepatitis A vaccine, pediatric/adolescent dosage, 3 dose schedule |
hepatitis A vaccine, pediatric/adolescent dosage, 3 dose schedule |
| 85 |
http://hl7.org/fhir/sid/cvx |
Hep A, unspecified formulation |
hepatitis A vaccine, unspecified formulation |
hepatitis A vaccine, unspecified formulation |
| 86 |
http://hl7.org/fhir/sid/cvx |
IG |
immune globulin, intramuscular |
immune globulin, intramuscular |
| 87 |
http://hl7.org/fhir/sid/cvx |
IGIV |
immune globulin, intravenous |
immune globulin, intravenous |
| 88 |
http://hl7.org/fhir/sid/cvx |
influenza, unspecified formulation |
influenza virus vaccine, unspecified formulation |
influenza virus vaccine, unspecified formulation |
| 89 |
http://hl7.org/fhir/sid/cvx |
polio, unspecified formulation |
poliovirus vaccine, unspecified formulation |
poliovirus vaccine, unspecified formulation |
| 90 |
http://hl7.org/fhir/sid/cvx |
rabies, unspecified formulation |
rabies vaccine, unspecified formulation |
rabies vaccine, unspecified formulation |
| 91 |
http://hl7.org/fhir/sid/cvx |
typhoid, unspecified formulation |
typhoid vaccine, unspecified formulation |
typhoid vaccine, unspecified formulation |
| 92 |
http://hl7.org/fhir/sid/cvx |
VEE, unspecified formulation |
Venezuelan equine encephalitis vaccine, unspecified formulation |
Venezuelan equine encephalitis vaccine, unspecified formulation |
| 93 |
http://hl7.org/fhir/sid/cvx |
RSV-MAb |
respiratory syncytial virus monoclonal antibody (palivizumab), intramuscular |
respiratory syncytial virus monoclonal antibody (palivizumab), intramuscular |
| 94 |
http://hl7.org/fhir/sid/cvx |
MMRV |
measles, mumps, rubella, and varicella virus vaccine |
measles, mumps, rubella, and varicella virus vaccine |
| 95 |
http://hl7.org/fhir/sid/cvx |
TST-OT tine test |
tuberculin skin test; old tuberculin, multipuncture device |
tuberculin skin test; old tuberculin, multipuncture device |
| 96 |
http://hl7.org/fhir/sid/cvx |
TST-PPD intradermal |
tuberculin skin test; purified protein derivative solution, intradermal |
tuberculin skin test; purified protein derivative solution, intradermal |
| 97 |
http://hl7.org/fhir/sid/cvx |
TST-PPD tine test |
tuberculin skin test; purified protein derivative, multipuncture device |
tuberculin skin test; purified protein derivative, multipuncture device |
| 98 |
http://hl7.org/fhir/sid/cvx |
TST, unspecified formulation |
tuberculin skin test; unspecified formulation |
tuberculin skin test; unspecified formulation |
| 99 |
http://hl7.org/fhir/sid/cvx |
RESERVED - do not use |
RESERVED - do not use |
RESERVED - do not use |
| 100 |
http://hl7.org/fhir/sid/cvx |
pneumococcal conjugate PCV 7 |
pneumococcal conjugate vaccine, 7 valent |
pneumococcal conjugate vaccine, 7 valent |
| 101 |
http://hl7.org/fhir/sid/cvx |
typhoid, ViCPs |
typhoid Vi capsular polysaccharide vaccine |
typhoid Vi capsular polysaccharide vaccine |
| 102 |
http://hl7.org/fhir/sid/cvx |
DTP-Hib-Hep B |
DTP- Haemophilus influenzae type b conjugate and hepatitis b vaccine |
DTP- Haemophilus influenzae type b conjugate and hepatitis b vaccine |
| 103 |
http://hl7.org/fhir/sid/cvx |
meningococcal C conjugate |
meningococcal C conjugate vaccine |
meningococcal C conjugate vaccine |
| 104 |
http://hl7.org/fhir/sid/cvx |
Hep A-Hep B |
hepatitis A and hepatitis B vaccine |
hepatitis A and hepatitis B vaccine |
| 105 |
http://hl7.org/fhir/sid/cvx |
vaccinia (smallpox) diluted |
vaccinia (smallpox) vaccine, diluted |
vaccinia (smallpox) vaccine, diluted |
| 106 |
http://hl7.org/fhir/sid/cvx |
DTaP, 5 pertussis antigens |
diphtheria, tetanus toxoids and acellular pertussis vaccine, 5 pertussis antigens |
diphtheria, tetanus toxoids and acellular pertussis vaccine, 5 pertussis antigens |
| 107 |
http://hl7.org/fhir/sid/cvx |
DTaP, unspecified formulation |
diphtheria, tetanus toxoids and acellular pertussis vaccine, unspecified formulation |
diphtheria, tetanus toxoids and acellular pertussis vaccine, unspecified formulation |
| 108 |
http://hl7.org/fhir/sid/cvx |
meningococcal ACWY, unspecified formulation |
meningococcal ACWY vaccine, unspecified formulation |
meningococcal ACWY vaccine, unspecified formulation |
| 109 |
http://hl7.org/fhir/sid/cvx |
pneumococcal, unspecified formulation |
pneumococcal vaccine, unspecified formulation |
pneumococcal vaccine, unspecified formulation |
| 110 |
http://hl7.org/fhir/sid/cvx |
DTaP-Hep B-IPV |
DTaP-hepatitis B and poliovirus vaccine |
DTaP-hepatitis B and poliovirus vaccine |
| 111 |
http://hl7.org/fhir/sid/cvx |
influenza, live, intranasal |
influenza virus vaccine, live, attenuated, for intranasal use |
influenza virus vaccine, live, attenuated, for intranasal use |
| 112 |
http://hl7.org/fhir/sid/cvx |
tetanus toxoid, unspecified formulation |
tetanus toxoid, unspecified formulation |
tetanus toxoid, unspecified formulation |
| 113 |
http://hl7.org/fhir/sid/cvx |
Td (adult), 5 Lf tetanus toxoid, preservative free, adsorbed |
tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (5 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid) |
tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (5 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid) |
| 114 |
http://hl7.org/fhir/sid/cvx |
meningococcal MCV4P |
meningococcal polysaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4P) |
meningococcal polysaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4P) |
| 115 |
http://hl7.org/fhir/sid/cvx |
Tdap |
tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine, adsorbed |
tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine, adsorbed |
| 116 |
http://hl7.org/fhir/sid/cvx |
rotavirus, pentavalent |
rotavirus, live, pentavalent vaccine |
rotavirus, live, pentavalent vaccine |
| 117 |
http://hl7.org/fhir/sid/cvx |
VZIG (IND) |
varicella zoster immune globulin (Investigational New Drug) |
varicella zoster immune globulin (Investigational New Drug) |
| 118 |
http://hl7.org/fhir/sid/cvx |
HPV, bivalent |
human papilloma virus vaccine, bivalent |
human papilloma virus vaccine, bivalent |
| 119 |
http://hl7.org/fhir/sid/cvx |
rotavirus, monovalent |
rotavirus, live, monovalent vaccine |
rotavirus, live, monovalent vaccine |
| 120 |
http://hl7.org/fhir/sid/cvx |
DTaP-Hib-IPV |
diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV) |
diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV) |
| 121 |
http://hl7.org/fhir/sid/cvx |
zoster live |
zoster vaccine, live |
zoster vaccine, live |
| 122 |
http://hl7.org/fhir/sid/cvx |
rotavirus, unspecified formulation |
rotavirus vaccine, unspecified formulation |
rotavirus vaccine, unspecified formulation |
| 123 |
http://hl7.org/fhir/sid/cvx |
influenza, H5N1-1203 |
influenza virus vaccine, H5N1, A/Vietnam/1203/2004 (national stockpile) |
influenza virus vaccine, H5N1, A/Vietnam/1203/2004 (national stockpile) |
| 125 |
http://hl7.org/fhir/sid/cvx |
Novel Influenza-H1N1-09, nasal |
Novel Influenza-H1N1-09, live virus for nasal administration |
Novel Influenza-H1N1-09, live virus for nasal administration |
| 126 |
http://hl7.org/fhir/sid/cvx |
Novel influenza-H1N1-09, preservative-free |
Novel influenza-H1N1-09, preservative-free, injectable |
Novel influenza-H1N1-09, preservative-free, injectable |
| 127 |
http://hl7.org/fhir/sid/cvx |
Novel influenza-H1N1-09 |
Novel influenza-H1N1-09, injectable |
Novel influenza-H1N1-09, injectable |
| 128 |
http://hl7.org/fhir/sid/cvx |
Novel Influenza-H1N1-09, all formulations |
Novel influenza-H1N1-09, all formulations |
Novel influenza-H1N1-09, all formulations |
| 129 |
http://hl7.org/fhir/sid/cvx |
Japanese Encephalitis, unspecified formulation |
Japanese Encephalitis vaccine, unspecified formulation |
Japanese Encephalitis vaccine, unspecified formulation |
| 130 |
http://hl7.org/fhir/sid/cvx |
DTaP-IPV |
Diphtheria, tetanus toxoids and acellular pertussis vaccine, and poliovirus vaccine, inactivated |
Diphtheria, tetanus toxoids and acellular pertussis vaccine, and poliovirus vaccine, inactivated |
| 131 |
http://hl7.org/fhir/sid/cvx |
typhus, historical |
Historical record of a typhus vaccination |
Historical record of a typhus vaccination |
| 132 |
http://hl7.org/fhir/sid/cvx |
DTaP-IPV-HIB-HEP B, historical |
Historical diphtheria and tetanus toxoids and acellular pertussis, poliovirus, Haemophilus b conjugate and hepatitis B (recombinant) vaccine. |
Historical diphtheria and tetanus toxoids and acellular pertussis, poliovirus, Haemophilus b conjugate and hepatitis B (recombinant) vaccine. |
| 133 |
http://hl7.org/fhir/sid/cvx |
Pneumococcal conjugate PCV 13 |
pneumococcal conjugate vaccine, 13 valent |
pneumococcal conjugate vaccine, 13 valent |
| 134 |
http://hl7.org/fhir/sid/cvx |
Japanese Encephalitis IM |
Japanese Encephalitis vaccine for intramuscular administration |
Japanese Encephalitis vaccine for intramuscular administration |
| 135 |
http://hl7.org/fhir/sid/cvx |
Influenza, high dose seasonal |
influenza, high dose seasonal, preservative-free |
influenza, high dose seasonal, preservative-free |
| 136 |
http://hl7.org/fhir/sid/cvx |
Meningococcal MCV4O |
meningococcal oligosaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4O) |
meningococcal oligosaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4O) |
| 137 |
http://hl7.org/fhir/sid/cvx |
HPV, unspecified formulation |
HPV, unspecified formulation |
HPV, unspecified formulation |
| 138 |
http://hl7.org/fhir/sid/cvx |
Td (adult) |
tetanus and diphtheria toxoids, not adsorbed, for adult use |
tetanus and diphtheria toxoids, not adsorbed, for adult use |
| 139 |
http://hl7.org/fhir/sid/cvx |
Td(adult) unspecified formulation |
Td(adult) unspecified formulation |
Td(adult) unspecified formulation |
| 140 |
http://hl7.org/fhir/sid/cvx |
Influenza, seasonal, injectable, preservative free |
Influenza, seasonal, injectable, preservative free |
Influenza, seasonal, injectable, preservative free |
| 141 |
http://hl7.org/fhir/sid/cvx |
Influenza, seasonal, injectable |
Influenza, seasonal, injectable |
Influenza, seasonal, injectable |
| 142 |
http://hl7.org/fhir/sid/cvx |
tetanus toxoid, not adsorbed |
tetanus toxoid, not adsorbed |
tetanus toxoid, not adsorbed |
| 143 |
http://hl7.org/fhir/sid/cvx |
Adenovirus types 4 and 7 |
Adenovirus, type 4 and type 7, live, oral |
Adenovirus, type 4 and type 7, live, oral |
| 144 |
http://hl7.org/fhir/sid/cvx |
influenza, seasonal, intradermal, preservative free |
seasonal influenza, intradermal, preservative free |
seasonal influenza, intradermal, preservative free |
| 145 |
http://hl7.org/fhir/sid/cvx |
RSV-MAb (new) |
respiratory syncytial virus monoclonal antibody (motavizumab), intramuscular |
respiratory syncytial virus monoclonal antibody (motavizumab), intramuscular |
| 146 |
http://hl7.org/fhir/sid/cvx |
DTaP,IPV,Hib,HepB |
Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus, Haemophilus b Conjugate (Meningococcal Protein Conjugate), and Hepatitis B (Recombinant) Vaccine. |
Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus, Haemophilus b Conjugate (Meningococcal Protein Conjugate), and Hepatitis B (Recombinant) Vaccine. |
| 147 |
http://hl7.org/fhir/sid/cvx |
meningococcal MCV4, unspecified formulation |
Meningococcal, MCV4, unspecified conjugate formulation(groups A, C, Y and W-135) |
Meningococcal, MCV4, unspecified conjugate formulation(groups A, C, Y and W-135) |
| 148 |
http://hl7.org/fhir/sid/cvx |
Meningococcal C/Y-HIB PRP |
Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine |
Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine |
| 149 |
http://hl7.org/fhir/sid/cvx |
influenza, live, intranasal, quadrivalent |
influenza, live, intranasal, quadrivalent |
influenza, live, intranasal, quadrivalent |
| 150 |
http://hl7.org/fhir/sid/cvx |
influenza, injectable, quadrivalent, preservative free |
Influenza, injectable, quadrivalent, preservative free |
Influenza, injectable, quadrivalent, preservative free |
| 151 |
http://hl7.org/fhir/sid/cvx |
influenza nasal, unspecified formulation |
influenza nasal, unspecified formulation |
influenza nasal, unspecified formulation |
| 152 |
http://hl7.org/fhir/sid/cvx |
Pneumococcal Conjugate, unspecified formulation |
Pneumococcal Conjugate, unspecified formulation |
Pneumococcal Conjugate, unspecified formulation |
| 153 |
http://hl7.org/fhir/sid/cvx |
Influenza, injectable, MDCK, preservative free |
Influenza, injectable, Madin Darby Canine Kidney, preservative free |
Influenza, injectable, Madin Darby Canine Kidney, preservative free |
| 154 |
http://hl7.org/fhir/sid/cvx |
Hep A, IG |
Hepatitis A immune globulin |
Hepatitis A immune globulin |
| 155 |
http://hl7.org/fhir/sid/cvx |
influenza, recombinant, injectable, preservative free |
Seasonal, trivalent, recombinant, injectable influenza vaccine, preservative free |
Seasonal, trivalent, recombinant, injectable influenza vaccine, preservative free |
| 156 |
http://hl7.org/fhir/sid/cvx |
Rho(D)-IG |
Rho(D) Immune globulin- IV or IM |
Rho(D) Immune globulin- IV or IM |
| 157 |
http://hl7.org/fhir/sid/cvx |
Rho(D) -IG IM |
Rho(D) Immune globulin - IM |
Rho(D) Immune globulin - IM |
| 158 |
http://hl7.org/fhir/sid/cvx |
influenza, injectable, quadrivalent |
influenza, injectable, quadrivalent, contains preservative |
influenza, injectable, quadrivalent, contains preservative |
| 159 |
http://hl7.org/fhir/sid/cvx |
Rho(D) - Unspecified formulation |
Rho(D) Unspecified formulation |
Rho(D) Unspecified formulation |
| 160 |
http://hl7.org/fhir/sid/cvx |
Influenza A monovalent (H5N1), ADJUVANTED-2013 |
Influenza A monovalent (H5N1), adjuvanted, National stockpile 2013 |
Influenza A monovalent (H5N1), adjuvanted, National stockpile 2013 |
| 161 |
http://hl7.org/fhir/sid/cvx |
Influenza, injectable,quadrivalent, preservative free, pediatric |
Influenza, injectable,quadrivalent, preservative free, pediatric |
Influenza, injectable,quadrivalent, preservative free, pediatric |
| 162 |
http://hl7.org/fhir/sid/cvx |
meningococcal B, recombinant |
meningococcal B vaccine, fully recombinant |
meningococcal B vaccine, fully recombinant |
| 163 |
http://hl7.org/fhir/sid/cvx |
meningococcal B, OMV |
meningococcal B vaccine, recombinant, OMV, adjuvanted |
meningococcal B vaccine, recombinant, OMV, adjuvanted |
| 164 |
http://hl7.org/fhir/sid/cvx |
meningococcal B, unspecified |
meningococcal B, unspecified formulation |
meningococcal B, unspecified formulation |
| 165 |
http://hl7.org/fhir/sid/cvx |
HPV9 |
Human Papillomavirus 9-valent vaccine |
Human Papillomavirus 9-valent vaccine |
| 166 |
http://hl7.org/fhir/sid/cvx |
influenza, intradermal, quadrivalent, preservative free |
influenza, intradermal, quadrivalent, preservative free, injectable |
influenza, intradermal, quadrivalent, preservative free, injectable |
| 167 |
http://hl7.org/fhir/sid/cvx |
meningococcal, unknown serogroups |
meningococcal vaccine of unknown formulation and unknown serogroups |
meningococcal vaccine of unknown formulation and unknown serogroups |
| 168 |
http://hl7.org/fhir/sid/cvx |
influenza, trivalent, adjuvanted |
Seasonal trivalent influenza vaccine, adjuvanted, preservative free |
Seasonal trivalent influenza vaccine, adjuvanted, preservative free |
| 169 |
http://hl7.org/fhir/sid/cvx |
Hep A, live attenuated |
Hep A, live attenuated-IM |
Hep A, live attenuated-IM |
| 170 |
http://hl7.org/fhir/sid/cvx |
DTAP/IPV/HIB - non-US |
non-US diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV) |
non-US diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV) |
| 171 |
http://hl7.org/fhir/sid/cvx |
Influenza, injectable, MDCK, preservative free, quadrivalent |
Influenza, injectable, Madin Darby Canine Kidney, preservative free, quadrivalent |
Influenza, injectable, Madin Darby Canine Kidney, preservative free, quadrivalent |
| 172 |
http://hl7.org/fhir/sid/cvx |
cholera, WC-rBS |
cholera, WC-rBS |
cholera, WC-rBS |
| 173 |
http://hl7.org/fhir/sid/cvx |
cholera, BivWC |
cholera, BivWC |
cholera, BivWC |
| 174 |
http://hl7.org/fhir/sid/cvx |
cholera, live attenuated |
cholera, live attenuated |
cholera, live attenuated |
| 175 |
http://hl7.org/fhir/sid/cvx |
Rabies - IM Diploid cell culture |
Human Rabies vaccine from human diploid cell culture |
Human Rabies vaccine from human diploid cell culture |
| 176 |
http://hl7.org/fhir/sid/cvx |
Rabies - IM fibroblast culture |
Human rabies vaccine from Chicken fibroblast culture |
Human rabies vaccine from Chicken fibroblast culture |
| 177 |
http://hl7.org/fhir/sid/cvx |
PCV10 |
pneumococcal conjugate vaccine, 10 valent |
pneumococcal conjugate vaccine, 10 valent |
| 178 |
http://hl7.org/fhir/sid/cvx |
OPV bivalent |
Non-US bivalent oral polio vaccine (types 1 and 3) |
Non-US bivalent oral polio vaccine (types 1 and 3) |
| 179 |
http://hl7.org/fhir/sid/cvx |
OPV ,monovalent, unspecified |
Non-US monovalent oral polio vaccine, unspecified formulation |
Non-US monovalent oral polio vaccine, unspecified formulation |
| 180 |
http://hl7.org/fhir/sid/cvx |
tetanus immune globulin |
tetanus immune globulin |
tetanus immune globulin |
| 181 |
http://hl7.org/fhir/sid/cvx |
anthrax immune globulin |
anthrax immune globulin |
anthrax immune globulin |
| 182 |
http://hl7.org/fhir/sid/cvx |
OPV, Unspecified |
Oral Polio Vaccine, Unspecified formulation |
Oral Polio Vaccine, Unspecified formulation |
| 183 |
http://hl7.org/fhir/sid/cvx |
Yellow fever vaccine - alt |
Yellow fever vaccine alternative formulation |
Yellow fever vaccine alternative formulation |
| 184 |
http://hl7.org/fhir/sid/cvx |
Yellow fever, unspecified formulation |
Yellow fever vaccine, unspecified formulation |
Yellow fever vaccine, unspecified formulation |
| 185 |
http://hl7.org/fhir/sid/cvx |
influenza, recombinant, quadrivalent,injectable, preservative free |
Seasonal, quadrivalent, recombinant, injectable influenza vaccine, preservative free |
Seasonal, quadrivalent, recombinant, injectable influenza vaccine, preservative free |
| 186 |
http://hl7.org/fhir/sid/cvx |
Influenza, injectable, MDCK, quadrivalent, preservative |
Influenza, injectable, Madin Darby Canine Kidney, quadrivalent with preservative |
Influenza, injectable, Madin Darby Canine Kidney, quadrivalent with preservative |
| 187 |
http://hl7.org/fhir/sid/cvx |
zoster recombinant |
zoster vaccine recombinant |
zoster vaccine recombinant |
| 188 |
http://hl7.org/fhir/sid/cvx |
zoster, unspecified formulation |
zoster vaccine, unspecified formulation |
zoster vaccine, unspecified formulation |
| 189 |
http://hl7.org/fhir/sid/cvx |
HepB-CpG |
Hepatitis B vaccine (recombinant), CpG adjuvanted |
Hepatitis B vaccine (recombinant), CpG adjuvanted |
| 190 |
http://hl7.org/fhir/sid/cvx |
Typhoid conjugate vaccine (TCV) |
Typhoid conjugate vaccine (non-US) |
Typhoid conjugate vaccine (non-US) |
| 191 |
http://hl7.org/fhir/sid/cvx |
meningococcal A polysaccharide (non-US) |
meningococcal A polysaccharide vaccine (non-US) |
meningococcal A polysaccharide vaccine (non-US) |
| 192 |
http://hl7.org/fhir/sid/cvx |
meningococcal AC polysaccharide (non-US) |
meningococcal AC polysaccharide vaccine (non-US) |
meningococcal AC polysaccharide vaccine (non-US) |
| 193 |
http://hl7.org/fhir/sid/cvx |
Hep A-Hep B, pediatric/adolescent |
hepatitis A and hepatitis B vaccine, pediatric/adolescent (non-US) |
hepatitis A and hepatitis B vaccine, pediatric/adolescent (non-US) |
| 194 |
http://hl7.org/fhir/sid/cvx |
Influenza, Southern Hemisphere |
influenza, Southern Hemisphere, unspecified formulation |
influenza, Southern Hemisphere, unspecified formulation |
| 195 |
http://hl7.org/fhir/sid/cvx |
DT, IPV adsorbed |
Diphtheria, Tetanus, Poliomyelitis adsorbed |
Diphtheria, Tetanus, Poliomyelitis adsorbed |
| 196 |
http://hl7.org/fhir/sid/cvx |
Td, adsorbed, preservative free, adult use, Lf unspecified |
tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use, Lf unspecified |
tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use, Lf unspecified |
| 197 |
http://hl7.org/fhir/sid/cvx |
influenza, high-dose, quadrivalent |
influenza, high-dose seasonal, quadrivalent, 0.7mL dose, preservative free |
influenza, high-dose seasonal, quadrivalent, 0.7mL dose, preservative free |
| 198 |
http://hl7.org/fhir/sid/cvx |
DTP-hepB-Hib Pentavalent Non-US |
Diphtheria, pertussis, tetanus, hepatitis B, Haemophilus Influenza Type b, (Pentavalent) |
Diphtheria, pertussis, tetanus, hepatitis B, Haemophilus Influenza Type b, (Pentavalent) |
| 200 |
http://hl7.org/fhir/sid/cvx |
influenza, Southern Hemisphere, pediatric, preservative free |
influenza, seasonal, Southern Hemisphere, quadrivalent, pediatric 0.25mL dose, preservative free |
influenza, seasonal, Southern Hemisphere, quadrivalent, pediatric 0.25mL dose, preservative free |
| 201 |
http://hl7.org/fhir/sid/cvx |
influenza, Southern Hemisphere, preservative free |
influenza, seasonal, Southern Hemisphere, quadrivalent, 0.5mL dose, no preservative |
influenza, seasonal, Southern Hemisphere, quadrivalent, 0.5mL dose, no preservative |
| 202 |
http://hl7.org/fhir/sid/cvx |
influenza, Southern Hemisphere, quadrivalent, with preservative |
influenza, seasonal, Southern Hemisphere, quadrivalent, 0.5mL dose, with preservative |
influenza, seasonal, Southern Hemisphere, quadrivalent, 0.5mL dose, with preservative |
| 203 |
http://hl7.org/fhir/sid/cvx |
meningococcal conjugate quadrivalent, MenACWY-TT (MCV4) |
meningococcal polysaccharide (groups A, C, Y, W-135) tetanus toxoid conjugate vaccine 0.5mL dose, preservative free |
meningococcal polysaccharide (groups A, C, Y, W-135) tetanus toxoid conjugate vaccine 0.5mL dose, preservative free |
| 204 |
http://hl7.org/fhir/sid/cvx |
Ebola Zaire vaccine, live, recombinant, 1mL dose |
Ebola Zaire vaccine, live, recombinant, 1mL dose |
Ebola Zaire vaccine, live, recombinant, 1mL dose |
| 205 |
http://hl7.org/fhir/sid/cvx |
Influenza vaccine, quadrivalent, adjuvanted |
influenza, seasonal vaccine, quadrivalent, adjuvanted, 0.5mL dose, preservative free |
influenza, seasonal vaccine, quadrivalent, adjuvanted, 0.5mL dose, preservative free |
| 206 |
http://hl7.org/fhir/sid/cvx |
Vaccinia, smallpox Mpox vaccine live, PF, SQ or ID injection |
Vaccinia, smallpox monkeypox vaccine, live attenuated, preservative free, subcutaneous or intradermal injection |
Vaccinia, smallpox monkeypox vaccine, live attenuated, preservative free, subcutaneous or intradermal injection |
| 207 |
http://hl7.org/fhir/sid/cvx |
COVID-19, mRNA, LNP-S, PF, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose |
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose |
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose |
| 208 |
http://hl7.org/fhir/sid/cvx |
COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose |
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose |
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose |
| 210 |
http://hl7.org/fhir/sid/cvx |
COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL |
SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-ChAdOx1, preservative free, 0.5 mL |
SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-ChAdOx1, preservative free, 0.5 mL |
| 211 |
http://hl7.org/fhir/sid/cvx |
COVID-19, subunit, rS-nanoparticle+Matrix-M1 Adjuvant, PF, 0.5 mL |
SARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein-nanoparticle+Matrix-M1 Adjuvant, preservative free, 0.5mL dose |
SARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein-nanoparticle+Matrix-M1 Adjuvant, preservative free, 0.5mL dose |
| 212 |
http://hl7.org/fhir/sid/cvx |
COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL |
SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-Ad26, preservative free, 0.5 mL |
SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-Ad26, preservative free, 0.5 mL |
| 213 |
http://hl7.org/fhir/sid/cvx |
SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED |
SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED |
SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED |
| 214 |
http://hl7.org/fhir/sid/cvx |
Ebola, unspecified |
Ebola, unspecified |
Ebola, unspecified |
| 215 |
http://hl7.org/fhir/sid/cvx |
Pneumococcal conjugate PCV15, polysaccharide CRM197 conjugate, adjuvant, PF |
Pneumococcal conjugate vaccine 15-valent (PCV15), polysaccharide CRM197 conjugate, adjuvant, preservative free |
Pneumococcal conjugate vaccine 15-valent (PCV15), polysaccharide CRM197 conjugate, adjuvant, preservative free |
| 216 |
http://hl7.org/fhir/sid/cvx |
Pneumococcal conjugate PCV20, polysaccharide CRM197 conjugate, adjuvant, PF |
Pneumococcal conjugate vaccine 20-valent (PCV20), polysaccharide CRM197 conjugate, adjuvant, preservative free |
Pneumococcal conjugate vaccine 20-valent (PCV20), polysaccharide CRM197 conjugate, adjuvant, preservative free |
| 217 |
http://hl7.org/fhir/sid/cvx |
COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose, tris-sucrose |
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose, tris-sucrose formulation |
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose, tris-sucrose formulation |
| 218 |
http://hl7.org/fhir/sid/cvx |
COVID-19, mRNA, LNP-S, PF, 10 mcg/0.2 mL dose, tris-sucrose |
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 10 mcg/0.2mL dose, tris-sucrose formulation |
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 10 mcg/0.2mL dose, tris-sucrose formulation |
| 219 |
http://hl7.org/fhir/sid/cvx |
COVID-19, mRNA, LNP-S, PF, 3 mcg/0.2 mL dose, tris-sucrose |
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 3 mcg/0.2mL dose, tris-sucrose formulation |
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 3 mcg/0.2mL dose, tris-sucrose formulation |
| 220 |
http://hl7.org/fhir/sid/cvx |
HepB recombinant, 3-antigen, Al(OH)3 |
Hepatitis B vaccine (recombinant), 3-antigen, Al(OH)3 adjuvanted |
Hepatitis B vaccine (recombinant), 3-antigen, Al(OH)3 adjuvanted |
| 221 |
http://hl7.org/fhir/sid/cvx |
COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL dose |
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 50 mcg/0.5 mL dose |
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 50 mcg/0.5 mL dose |
| 222 |
http://hl7.org/fhir/sid/cvx |
Tick-borne encephalitis, unspecified |
Tick-borne encephalitis vaccine, unspecified |
Tick-borne encephalitis vaccine, unspecified |
| 223 |
http://hl7.org/fhir/sid/cvx |
Tick-borne encephalitis, inactivated, PF, 0.25mL |
Tick-borne encephalitis vaccine, inactivated, preservative free, 0.25mL dose |
Tick-borne encephalitis vaccine, inactivated, preservative free, 0.25mL dose |
| 224 |
http://hl7.org/fhir/sid/cvx |
Tick-borne encephalitis, inactivated, PF, 0.5mL |
Tick-borne encephalitis vaccine, inactivated, preservative free, 0.5mL dose |
Tick-borne encephalitis vaccine, inactivated, preservative free, 0.5mL dose |
| 225 |
http://hl7.org/fhir/sid/cvx |
COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 5mcg/0.5mL |
SARS-COV-2 (COVID-19) vaccine, D614, prefusion spike recombinant protein subunit (CoV2 preS dTM), AS03 adjuvant added, preservative free, 5mcg/0.5mL dose |
SARS-COV-2 (COVID-19) vaccine, D614, prefusion spike recombinant protein subunit (CoV2 preS dTM), AS03 adjuvant added, preservative free, 5mcg/0.5mL dose |
| 226 |
http://hl7.org/fhir/sid/cvx |
COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 10mcg/0.5mL |
SARS-COV-2 (COVID-19) vaccine, D614, prefusion spike recombinant protein subunit (CoV2 preS dTM), AS03 adjuvant added, preservative free, 10mcg/0.5mL dose |
SARS-COV-2 (COVID-19) vaccine, D614, prefusion spike recombinant protein subunit (CoV2 preS dTM), AS03 adjuvant added, preservative free, 10mcg/0.5mL dose |
| 227 |
http://hl7.org/fhir/sid/cvx |
COVID-19, mRNA, LNP-S, PF, pediatric 50 mcg/0.5 mL dose |
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, pediatric 50 mcg/0.5 mL dose |
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, pediatric 50 mcg/0.5 mL dose |
| 228 |
http://hl7.org/fhir/sid/cvx |
COVID-19, mRNA, LNP-S, PF, pediatric 25 mcg/0.25 mL dose |
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, pediatric 25 mcg/0.25 mL dose |
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, pediatric 25 mcg/0.25 mL dose |
| 229 |
http://hl7.org/fhir/sid/cvx |
COVID-19, mRNA, LNP-S, bivalent, PF, 50 mcg/0.5 mL or 25mcg/0.25 mL dose |
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 50 mcg/0.5 mL or 25 mcg/0.25 mL dose |
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 50 mcg/0.5 mL or 25 mcg/0.25 mL dose |
| 230 |
http://hl7.org/fhir/sid/cvx |
COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL |
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 10 mcg/0.2 mL dose |
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 10 mcg/0.2 mL dose |
| 231 |
http://hl7.org/fhir/sid/cvx |
influenza, Southern Hemisphere, high-dose, quadrivalent |
influenza, seasonal, Southern Hemisphere, high-dose, quadrivalent, 0.7mL dose, preservative free |
influenza, seasonal, Southern Hemisphere, high-dose, quadrivalent, 0.7mL dose, preservative free |
| 300 |
http://hl7.org/fhir/sid/cvx |
COVID-19, mRNA, LNP-S, bivalent, PF, 30 mcg/0.3 mL dose |
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 30 mcg/0.3 mL dose, tris-sucrose formulation |
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 30 mcg/0.3 mL dose, tris-sucrose formulation |
| 301 |
http://hl7.org/fhir/sid/cvx |
COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL dose |
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 10 mcg/0.2 mL dose, tris-sucrose formulation |
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 10 mcg/0.2 mL dose, tris-sucrose formulation |
| 302 |
http://hl7.org/fhir/sid/cvx |
COVID-19, mRNA, LNP-S, bivalent, PF, 3 mcg/0.2 mL dose |
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 3 mcg/0.2 mL dose, tris-sucrose formulation |
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, bivalent, preservative free, 3 mcg/0.2 mL dose, tris-sucrose formulation |
| 303 |
http://hl7.org/fhir/sid/cvx |
RSV, recombinant, protein subunit RSVpreF, adjuvant reconstituted, 0.5 mL, PF |
Respiratory syncytial virus (RSV), vaccine, recombinant, protein subunit RSV prefusion F, adjuvant reconstituted, 0.5 mL, preservative free |
Respiratory syncytial virus (RSV), vaccine, recombinant, protein subunit RSV prefusion F, adjuvant reconstituted, 0.5 mL, preservative free |
| 304 |
http://hl7.org/fhir/sid/cvx |
Respiratory syncytial virus (RSV), unspecified |
Respiratory syncytial virus (RSV), unspecified |
Respiratory syncytial virus (RSV), unspecified |
| 305 |
http://hl7.org/fhir/sid/cvx |
RSV, bivalent, protein subunit RSVpreF, diluent reconstituted, 0.5 mL, PF |
Respiratory syncytial virus (RSV), vaccine, bivalent, protein subunit RSV prefusion F, diluent reconstituted, 0.5 mL, preservative free |
Respiratory syncytial virus (RSV), vaccine, bivalent, protein subunit RSV prefusion F, diluent reconstituted, 0.5 mL, preservative free |
| 306 |
http://hl7.org/fhir/sid/cvx |
RSV, mAb, nirsevimab-alip, 0.5 mL, neonate to 24 months |
Respiratory syncytial virus (RSV) monoclonal antibody, IgG1κ , (nirsevimab-alip), 0.5 mL, neonates and children to 24 months |
Respiratory syncytial virus (RSV) monoclonal antibody, IgG1κ , (nirsevimab-alip), 0.5 mL, neonates and children to 24 months |
| 307 |
http://hl7.org/fhir/sid/cvx |
RSV, mAb, nirsevimab-alip, 1 mL, neonate to 24 months |
Respiratory syncytial virus (RSV) monoclonal antibody, IgG1κ , (nirsevimab-alip), 1 mL, neonates and children to 24 months |
Respiratory syncytial virus (RSV) monoclonal antibody, IgG1κ , (nirsevimab-alip), 1 mL, neonates and children to 24 months |
| 308 |
http://hl7.org/fhir/sid/cvx |
COVID-19, mRNA, LNP-S, PF, tris-sucrose, 3 mcg/0.3 mL |
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 3 mcg/0.3 mL dose |
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 3 mcg/0.3 mL dose |
| 309 |
http://hl7.org/fhir/sid/cvx |
COVID-19, mRNA, LNP-S, PF, tris-sucrose, 30 mcg/0.3 mL |
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 30 mcg/0.3 mL dose |
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 30 mcg/0.3 mL dose |
| 310 |
http://hl7.org/fhir/sid/cvx |
COVID-19, mRNA, LNP-S, PF, tris-sucrose, 10 mcg/0.3 mL |
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 10 mcg/0.3 mL dose |
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, tris-sucrose, 10 mcg/0.3 mL dose |
| 311 |
http://hl7.org/fhir/sid/cvx |
COVID-19, mRNA, LNP-S, PF, 25 mcg/0.25 mL |
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 25 mcg/0.25 mL dose |
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 25 mcg/0.25 mL dose |
| 312 |
http://hl7.org/fhir/sid/cvx |
COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL |
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 50 mcg/0.5 mL dose |
SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 50 mcg/0.5 mL dose |
| 313 |
http://hl7.org/fhir/sid/cvx |
COVID-19, subunit, rS-nanoparticle, adjuvanted, PF, 5 mcg/0.5 mL |
SARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein-nanoparticle+Matrix-M1 Adjuvant, preservative free, 5 mcg/0.5 mL dose |
SARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein-nanoparticle+Matrix-M1 Adjuvant, preservative free, 5 mcg/0.5 mL dose |
| 314 |
http://hl7.org/fhir/sid/cvx |
Respiratory syncytial virus (RSV) vaccine, unspecified |
Respiratory syncytial virus (RSV) vaccine, unspecified |
Respiratory syncytial virus (RSV) vaccine, unspecified |
| 315 |
http://hl7.org/fhir/sid/cvx |
Respiratory syncytial virus (RSV) MAB, unspecified |
Respiratory syncytial virus (RSV) monoclonal antibody (MAB), unspecified |
Respiratory syncytial virus (RSV) monoclonal antibody (MAB), unspecified |
| 316 |
http://hl7.org/fhir/sid/cvx |
meningococcal polysaccharide (MenACWY-TT conjugate), (MenB), PF |
meningococcal polysaccharide (groups A, C, Y, W) tetanus toxoid conjugate, meningococcal B recombinant vaccine, 0.5mL, preservative free |
meningococcal polysaccharide (groups A, C, Y, W) tetanus toxoid conjugate, meningococcal B recombinant vaccine, 0.5mL, preservative free |
| 317 |
http://hl7.org/fhir/sid/cvx |
Chikungunya live attenuated vaccine, 0.5 mL, PF |
Chikungunya, live attenuated vaccine, 0.5 mL, preservative free |
Chikungunya, live attenuated vaccine, 0.5 mL, preservative free |
| 500 |
http://hl7.org/fhir/sid/cvx |
COVID-19 Non-US Vaccine, Product Unknown |
SARS-COV-2 COVID-19 Non-US Vaccine, Specific Product Unknown |
SARS-COV-2 COVID-19 Non-US Vaccine, Specific Product Unknown |
| 501 |
http://hl7.org/fhir/sid/cvx |
COVID-19 IV Non-US Vaccine (QAZCOVID-IN) |
SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (QAZCOVID-IN) |
SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (QAZCOVID-IN) |
| 502 |
http://hl7.org/fhir/sid/cvx |
COVID-19 IV Non-US Vaccine (COVAXIN) |
SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (COVAXIN) |
SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (COVAXIN) |
| 503 |
http://hl7.org/fhir/sid/cvx |
COVID-19 LAV Non-US Vaccine (COVIVAC) |
SARS-COV-2 COVID-19 Live Attenuated Virus Non-US Vaccine Product (COVIVAC) |
SARS-COV-2 COVID-19 Live Attenuated Virus Non-US Vaccine Product (COVIVAC) |
| 504 |
http://hl7.org/fhir/sid/cvx |
COVID-19 VVnr Non-US Vaccine (Sputnik Light) |
SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (Sputnik Light) |
SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (Sputnik Light) |
| 505 |
http://hl7.org/fhir/sid/cvx |
COVID-19 VVnr Non-US Vaccine (Sputnik V) |
SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (Sputnik V) |
SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (Sputnik V) |
| 506 |
http://hl7.org/fhir/sid/cvx |
COVID-19 VVnr Non-US Vaccine (CanSino Biological Inc./Beijing Institute of Biotechnology |
SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (CONVIDECIA), CanSino Biological Inc./Beijing Institute of Biotechnology |
SARS-COV-2 COVID-19 Viral Vector Non-replicating Non-US Vaccine Product (CONVIDECIA), CanSino Biological Inc./Beijing Institute of Biotechnology |
| 507 |
http://hl7.org/fhir/sid/cvx |
COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom Biopharm + Inst of Micro, Chinese Acad of Sciences) |
SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Anhui Zhifei Longcom Biopharmaceutical + Institute of Microbiology, Chinese Academy of Sciences) |
SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Anhui Zhifei Longcom Biopharmaceutical + Institute of Microbiology, Chinese Academy of Sciences) |
| 508 |
http://hl7.org/fhir/sid/cvx |
COVID-19 PS Non-US Vaccine (Jiangsu Province Centers for Disease Control and Prevention) |
SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Jiangsu Province Centers for Disease Control and Prevention) |
SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Jiangsu Province Centers for Disease Control and Prevention) |
| 509 |
http://hl7.org/fhir/sid/cvx |
COVID-19 PS Non-US Vaccine (EpiVacCorona) |
SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (EpiVacCorona) |
SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (EpiVacCorona) |
| 510 |
http://hl7.org/fhir/sid/cvx |
COVID-19 IV Non-US Vaccine (BIBP, Sinopharm) |
SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (BIBP, Sinopharm) |
SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (BIBP, Sinopharm) |
| 511 |
http://hl7.org/fhir/sid/cvx |
COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac) |
SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (CoronaVac, Sinovac) |
SARS-COV-2 COVID-19 Inactivated Virus Non-US Vaccine Product (CoronaVac, Sinovac) |
| 512 |
http://hl7.org/fhir/sid/cvx |
SARS-COV-2 COVID-19 VLP Non-US Vaccine (Medicago, Covifenz) |
SARS-COV-2 COVID-19 Virus Like Particle (VLP) Non-US Vaccine Product (Medicago, Covifenz) |
SARS-COV-2 COVID-19 Virus Like Particle (VLP) Non-US Vaccine Product (Medicago, Covifenz) |
| 513 |
http://hl7.org/fhir/sid/cvx |
SARS-COV-2 COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom, Zifivax) |
SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Anhui Zhifei Longcom, Zifivax) |
SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Anhui Zhifei Longcom, Zifivax) |
| 514 |
http://hl7.org/fhir/sid/cvx |
SARS-COV-2 COVID-19 DNA Non-US Vaccine (Zydus Cadila, ZyCoV-D) |
SARS-COV-2 COVID-19 DNA Non-US Vaccine Product (Zydus Cadila, ZyCoV-D) |
SARS-COV-2 COVID-19 DNA Non-US Vaccine Product (Zydus Cadila, ZyCoV-D) |
| 515 |
http://hl7.org/fhir/sid/cvx |
SARS-COV-2 COVID-19 PS Non-US Vaccine (Medigen, MVC-COV1901) |
SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Medigen, MVC-COV1901) |
SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Medigen, MVC-COV1901) |
| 516 |
http://hl7.org/fhir/sid/cvx |
COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC) |
SARS-COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC) |
SARS-COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC) |
| 517 |
http://hl7.org/fhir/sid/cvx |
SARS-COV-2 COVID-19 PS Non-US Vaccine (Biological E Limited, Corbevax) |
SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Biological E Limited, Corbevax) |
SARS-COV-2 COVID-19 Protein Subunit Non-US Vaccine Product (Biological E Limited, Corbevax) |
| 518 |
http://hl7.org/fhir/sid/cvx |
COVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva) |
SARS-COV-2 COVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva) |
SARS-COV-2 COVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva) |
| 519 |
http://hl7.org/fhir/sid/cvx |
COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna |
SARS-COV-2 COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna |
SARS-COV-2 COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna |
| 520 |
http://hl7.org/fhir/sid/cvx |
COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product, Pfizer-BioNTech |
SARS-COV-2 COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product (Comirnaty Bivalent), Pfizer-BioNTech |
SARS-COV-2 COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product (Comirnaty Bivalent), Pfizer-BioNTech |
| 521 |
http://hl7.org/fhir/sid/cvx |
COVID-19 SP, protein-based, adjuvanted (VidPrevtyn Beta), Sanofi-GSK |
SARS-COV-2 (COVID-19) vaccine SP, protein-based, adjuvanted, B.1.351 strain (VidPrevtyn Beta), Sanofi-GSK |
SARS-COV-2 (COVID-19) vaccine SP, protein-based, adjuvanted, B.1.351 strain (VidPrevtyn Beta), Sanofi-GSK |
| 801 |
http://hl7.org/fhir/sid/cvx |
AS03 Adjuvant |
AS03 Adjuvant |
AS03 Adjuvant |
| 998 |
http://hl7.org/fhir/sid/cvx |
no vaccine administered |
no vaccine administered |
no vaccine administered |
| 999 |
http://hl7.org/fhir/sid/cvx |
unknown |
unknown vaccine or immune globulin |
unknown vaccine or immune globulin |
| AGRPAL |
urn:oid:1.2.36.1.2001.1005.17 |
Agrippal |
|
|
| AVAXM |
urn:oid:1.2.36.1.2001.1005.17 |
Avaxim |
|
|
| BCG |
urn:oid:1.2.36.1.2001.1005.17 |
BCG |
|
|
| CDT |
urn:oid:1.2.36.1.2001.1005.17 |
CDT |
|
|
| CMX |
urn:oid:1.2.36.1.2001.1005.17 |
COMVAX |
|
|
| DTP |
urn:oid:1.2.36.1.2001.1005.17 |
Triple Antigen |
|
|
| DTPA |
urn:oid:1.2.36.1.2001.1005.17 |
DTPa |
|
|
| ENGP |
urn:oid:1.2.36.1.2001.1005.17 |
Engerix B |
|
|
| FLRIX |
urn:oid:1.2.36.1.2001.1005.17 |
Fluarix |
|
|
| FLUVAX |
urn:oid:1.2.36.1.2001.1005.17 |
Fluvax |
|
|
| FLVRN |
urn:oid:1.2.36.1.2001.1005.17 |
Fluvirin |
|
|
| FVXJNR |
urn:oid:1.2.36.1.2001.1005.17 |
Fluvax Junior |
|
|
| GNDIP |
urn:oid:1.2.36.1.2001.1005.17 |
Diphtheria |
|
|
| GNFLU |
urn:oid:1.2.36.1.2001.1005.17 |
Influenza |
|
|
| GNHEP |
urn:oid:1.2.36.1.2001.1005.17 |
Hepatitis B |
|
|
| GNHIB |
urn:oid:1.2.36.1.2001.1005.17 |
HIB |
|
|
| GNHPA |
urn:oid:1.2.36.1.2001.1005.17 |
Hepatitis A |
|
|
| GNJEN |
urn:oid:1.2.36.1.2001.1005.17 |
Japanese Encephalitis |
|
|
| GNMEA |
urn:oid:1.2.36.1.2001.1005.17 |
Measles |
|
|
| GNMEN |
urn:oid:1.2.36.1.2001.1005.17 |
Meningococcal C |
|
|
| GNMUM |
urn:oid:1.2.36.1.2001.1005.17 |
Mumps |
|
|
| GNPNE |
urn:oid:1.2.36.1.2001.1005.17 |
Pneumococcal |
|
|
| GNPOL |
urn:oid:1.2.36.1.2001.1005.17 |
Polio |
|
|
| GNROX |
urn:oid:1.2.36.1.2001.1005.17 |
Rotavirus |
|
|
| GNRUB |
urn:oid:1.2.36.1.2001.1005.17 |
Rubella |
|
|
| GNTET |
urn:oid:1.2.36.1.2001.1005.17 |
Tetanus |
|
|
| GNVAR |
urn:oid:1.2.36.1.2001.1005.17 |
Varicella |
|
|
| HATWNJ |
urn:oid:1.2.36.1.2001.1005.17 |
Twinrix Junior |
|
|
| HAVAQ |
urn:oid:1.2.36.1.2001.1005.17 |
Vaqta Paed/Adol |
|
|
| HAVJ |
urn:oid:1.2.36.1.2001.1005.17 |
Havrix Junior |
|
|
| HBOC |
urn:oid:1.2.36.1.2001.1005.17 |
HibTITER |
|
|
| HBV |
urn:oid:1.2.36.1.2001.1005.17 |
HBV |
|
|
| HBVP |
urn:oid:1.2.36.1.2001.1005.17 |
HBVAX II |
|
|
| HBX |
urn:oid:1.2.36.1.2001.1005.17 |
Hiberix |
|
|
| IFHX |
urn:oid:1.2.36.1.2001.1005.17 |
Infanrix Hexa |
|
|
| IFIP |
urn:oid:1.2.36.1.2001.1005.17 |
Infanrix-IPV |
|
|
| IFPA |
urn:oid:1.2.36.1.2001.1005.17 |
Infanrix Penta |
|
|
| IFX |
urn:oid:1.2.36.1.2001.1005.17 |
Infanrix |
|
|
| IFXB |
urn:oid:1.2.36.1.2001.1005.17 |
InfanrixHepB |
|
|
| INFLUV |
urn:oid:1.2.36.1.2001.1005.17 |
Influvac |
|
|
| IPV |
urn:oid:1.2.36.1.2001.1005.17 |
IPOL |
|
|
| JEVAX |
urn:oid:1.2.36.1.2001.1005.17 |
JE-VAX |
|
|
| MENJUG |
urn:oid:1.2.36.1.2001.1005.17 |
Menjugate |
|
|
| MENTEC |
urn:oid:1.2.36.1.2001.1005.17 |
Meningitec |
|
|
| MENUME |
urn:oid:1.2.36.1.2001.1005.17 |
Menomune |
|
|
| MENVAX |
urn:oid:1.2.36.1.2001.1005.17 |
Mencevax ACWY |
|
|
| MMR |
urn:oid:1.2.36.1.2001.1005.17 |
MMR |
|
|
| MMRCSL |
urn:oid:1.2.36.1.2001.1005.17 |
MMR II |
|
|
| MMRSKB |
urn:oid:1.2.36.1.2001.1005.17 |
Priorix |
|
|
| MNTRX |
urn:oid:1.2.36.1.2001.1005.17 |
Menitorix |
|
|
| NEISVC |
urn:oid:1.2.36.1.2001.1005.17 |
NeisVac-C |
|
|
| OPV |
urn:oid:1.2.36.1.2001.1005.17 |
Polio |
|
|
| P |
urn:oid:1.2.36.1.2001.1005.17 |
Pertussis |
|
|
| PANVAX |
urn:oid:1.2.36.1.2001.1005.17 |
Panvax |
|
|
| PDCL |
urn:oid:1.2.36.1.2001.1005.17 |
Pediacel |
|
|
| PLCL |
urn:oid:1.2.36.1.2001.1005.17 |
Poliacel |
|
|
| PNEUMO |
urn:oid:1.2.36.1.2001.1005.17 |
Pneumovax |
|
|
| PRPD |
urn:oid:1.2.36.1.2001.1005.17 |
ProHIBit |
|
|
| PROQAD |
urn:oid:1.2.36.1.2001.1005.17 |
ProQuad |
|
|
| PRPOMP |
urn:oid:1.2.36.1.2001.1005.17 |
PedvaxHIB |
|
|
| PRPT |
urn:oid:1.2.36.1.2001.1005.17 |
ActHIB |
|
|
| PRVNR |
urn:oid:1.2.36.1.2001.1005.17 |
Prevenar 7 |
|
|
| PRVTH |
urn:oid:1.2.36.1.2001.1005.17 |
Prevenar 13 |
|
|
| PRXTEX |
urn:oid:1.2.36.1.2001.1005.17 |
Priorix-Tetra |
|
|
| QDCL |
urn:oid:1.2.36.1.2001.1005.17 |
Quadracel |
|
|
| ROTRIX |
urn:oid:1.2.36.1.2001.1005.17 |
Rotarix |
|
|
| ROTTEQ |
urn:oid:1.2.36.1.2001.1005.17 |
Rotateq |
|
|
| SYNFLX |
urn:oid:1.2.36.1.2001.1005.17 |
Synflorix |
|
|
| TCL |
urn:oid:1.2.36.1.2001.1005.17 |
Tripacel |
|
|
| VAXGRP |
urn:oid:1.2.36.1.2001.1005.17 |
Vaxigrip |
|
|
| VGRJNR |
urn:oid:1.2.36.1.2001.1005.17 |
Vaxigrip Junior |
|
|
| VLRIX |
urn:oid:1.2.36.1.2001.1005.17 |
Varilrix |
|
|
| VRVAX |
urn:oid:1.2.36.1.2001.1005.17 |
Varivax |
|
|